HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.

AbstractABSTRACT:
Distinguishing porocarcinoma from squamous cell carcinoma (SCC) is clinically significant; however, differential diagnosis can often be challenging. This study sought to confirm the diagnostic utility of cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 immunohistochemistry in distinguishing porocarcinoma from SCC. Immunohistochemical analysis of cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 in 14 porocarcinomas and 22 SCCs was performed; the extents and intensities of expression of these markers were recorded. The statistical associations of the immunoexpression between porocarcinoma and SCC were analyzed using the Pearson χ2 test. Cytokeratin 19 was positive in 13 (92.9%) of 14 porocarcinomas, and for all the positive cases, staining was strong and evident in >20% of the tumor cells. By contrast, 9 (40.9%) of 22 SCCs expressed cytokeratin 19 (P = 0.0018), of which 6 showed extremely focal (≤10% of the tumor cells) expression. Of the 14 porocarcinomas, 11 (78.6%) cases showed c-KIT positivity, whereas only 3 of 22 SCCs (13.6%) expressed c-KIT focally (P = 0.0001). In addition, BerEP4 immunostaining differed between porocarcinomas and SCCs (57.1% vs. 9.1%, respectively; P = 0.0017). However, no significant difference between the groups was reported in terms of GATA3 expression (57.1% vs. 72.7%, respectively; P = 0.3336). NUTM1 was expressed in 4/14 (28.6%) porocarcinomas but not in the SCCs. Immunohistochemistry for cytokeratin 19, c-KIT, and BerEP4 could be helpful in distinguishing porocarcinomas from SCCs. In addition, NUTM1 immunoexpression is highly specific, although not sensitive, to porocarcinomas. GATA3 immunohistochemistry has no meaningful implications in the differential diagnosis of porocarcinoma and SCC.
AuthorsKeisuke Goto, Misawo Ishikawa, Kengo Hamada, Koji Muramatsu, Miho Naka, Keiichiro Honma, Takashi Sugino
JournalThe American Journal of dermatopathology (Am J Dermatopathol) Vol. 43 Issue 11 Pg. 781-787 (Nov 01 2021) ISSN: 1533-0311 [Electronic] United States
PMID33767067 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • GATA3 Transcription Factor
  • GATA3 protein, human
  • KRT19 protein, human
  • Keratin-19
  • NUTM1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • human epithelial antigen-125
  • KIT protein, human
  • Proto-Oncogene Proteins c-kit
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Squamous Cell (diagnosis, metabolism)
  • Diagnosis, Differential
  • Eccrine Porocarcinoma (diagnosis, metabolism)
  • Female
  • GATA3 Transcription Factor (metabolism)
  • Humans
  • Immunohistochemistry
  • Keratin-19 (metabolism)
  • Male
  • Middle Aged
  • Neoplasm Proteins (metabolism)
  • Nuclear Proteins (metabolism)
  • Proto-Oncogene Proteins c-kit (metabolism)
  • Sweat Gland Neoplasms (diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: